Alternative Medicines and Therapies Comprehensive Study by Type (Mud Therapy, Reiki, Oil Massage Therapy, Magnetic Therapy, Some Breathing Exercises, Meditation, Yoga, Osteopathic Manipulation), Application (Hospital , Clinic), Distribution Channel (Direct Sales, E-Sales, Distance Correspondence) Players and Region - Global Market Outlook to 2030

Alternative Medicines and Therapies Market by XX Submarkets | Forecast Years 2024-2030  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Alternative Medicines and Therapies
Alternative medicine and therapies refer to any health treatment not standard in Western medical practice. It is referred to as complementary medicine. Its aims to achieve the healing effects of medicine, but which lacks biological plausibility and is untested, untestable or proven ineffective.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Alternative Medicines and Therapies market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Weleda (Switzerland), Cipla (India), Sante Verte Lab (France), Sandoz International GmbH (Germany), Biocon Ltd (India), Dr. Reddy's Laboratories (India), Wright Health Group Ltd. (United Kingdom), Nordic Nutraceuticals (Denmark) and Pure encapsulations, LLC (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Alternative Medicines and Therapies market by Type (Mud Therapy, Reiki, Oil Massage Therapy, Magnetic Therapy, Some Breathing Exercises, Meditation, Yoga and Osteopathic Manipulation), Application (Hospital  and Clinic) and Region.



On the basis of geography, the market of Alternative Medicines and Therapies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Direct Sales will boost the Alternative Medicines and Therapies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Health Care Expenditure

Market Growth Drivers:
Increased Adoption of Alternative Medicine and Therapies and Increased Prevalence of Chronic Diseases

Challenges:
Stringent Government Rules and Regulations

Restraints:
Side Effects of Alternative Medicine and Therapies

Opportunities:
Growing Geriatric Population Worldwide and Growth in the Healthcare Industry

Market Leaders and their expansionary development strategies
In October 2023, Shorla Oncology a US-Ireland specialty pharmaceutical company, and Therakind Ltd , a UK-based specialty pharmaceutical company has acquired Jylamvo, an oncology and autoimmune drug, for the US market. The therapy has been approved by the US Food and Drug Administration (FDA).This acquisition will provide a much-needed treatment to patients in need



Key Target Audience
Alternative Medicines and Therapies Providers, Distributors, Emerging Companies, Research Professionals and End-users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Mud Therapy
  • Reiki
  • Oil Massage Therapy
  • Magnetic Therapy
  • Some Breathing Exercises
  • Meditation
  • Yoga
  • Osteopathic Manipulation
By Application
  • Hospital 
  • Clinic
By Distribution Channel
  • Direct Sales
  • E-Sales
  • Distance Correspondence

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Adoption of Alternative Medicine and Therapies
      • 3.2.2. Increased Prevalence of Chronic Diseases
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increasing Health Care Expenditure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Alternative Medicines and Therapies, by Type, Application, Distribution Channel and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Alternative Medicines and Therapies (Value)
      • 5.2.1. Global Alternative Medicines and Therapies by: Type (Value)
        • 5.2.1.1. Mud Therapy
        • 5.2.1.2. Reiki
        • 5.2.1.3. Oil Massage Therapy
        • 5.2.1.4. Magnetic Therapy
        • 5.2.1.5. Some Breathing Exercises
        • 5.2.1.6. Meditation
        • 5.2.1.7. Yoga
        • 5.2.1.8. Osteopathic Manipulation
      • 5.2.2. Global Alternative Medicines and Therapies by: Application (Value)
        • 5.2.2.1. Hospital 
        • 5.2.2.2. Clinic
      • 5.2.3. Global Alternative Medicines and Therapies by: Distribution Channel (Value)
        • 5.2.3.1. Direct Sales
        • 5.2.3.2. E-Sales
        • 5.2.3.3. Distance Correspondence
      • 5.2.4. Global Alternative Medicines and Therapies Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Alternative Medicines and Therapies: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Weleda (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cipla (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Sante Verte Lab (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sandoz International GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Biocon Ltd (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Dr. Reddy's Laboratories (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Wright Health Group Ltd. (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Nordic Nutraceuticals (Denmark)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pure encapsulations, LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Alternative Medicines and Therapies Sale, by Type, Application, Distribution Channel and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Alternative Medicines and Therapies (Value)
      • 7.2.1. Global Alternative Medicines and Therapies by: Type (Value)
        • 7.2.1.1. Mud Therapy
        • 7.2.1.2. Reiki
        • 7.2.1.3. Oil Massage Therapy
        • 7.2.1.4. Magnetic Therapy
        • 7.2.1.5. Some Breathing Exercises
        • 7.2.1.6. Meditation
        • 7.2.1.7. Yoga
        • 7.2.1.8. Osteopathic Manipulation
      • 7.2.2. Global Alternative Medicines and Therapies by: Application (Value)
        • 7.2.2.1. Hospital 
        • 7.2.2.2. Clinic
      • 7.2.3. Global Alternative Medicines and Therapies by: Distribution Channel (Value)
        • 7.2.3.1. Direct Sales
        • 7.2.3.2. E-Sales
        • 7.2.3.3. Distance Correspondence
      • 7.2.4. Global Alternative Medicines and Therapies Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Alternative Medicines and Therapies: by Type(USD Million)
  • Table 2. Alternative Medicines and Therapies Mud Therapy , by Region USD Million (2018-2023)
  • Table 3. Alternative Medicines and Therapies Reiki , by Region USD Million (2018-2023)
  • Table 4. Alternative Medicines and Therapies Oil Massage Therapy , by Region USD Million (2018-2023)
  • Table 5. Alternative Medicines and Therapies Magnetic Therapy , by Region USD Million (2018-2023)
  • Table 6. Alternative Medicines and Therapies Some Breathing Exercises , by Region USD Million (2018-2023)
  • Table 7. Alternative Medicines and Therapies Meditation , by Region USD Million (2018-2023)
  • Table 8. Alternative Medicines and Therapies Yoga , by Region USD Million (2018-2023)
  • Table 9. Alternative Medicines and Therapies Osteopathic Manipulation , by Region USD Million (2018-2023)
  • Table 10. Alternative Medicines and Therapies: by Application(USD Million)
  • Table 11. Alternative Medicines and Therapies Hospital  , by Region USD Million (2018-2023)
  • Table 12. Alternative Medicines and Therapies Clinic , by Region USD Million (2018-2023)
  • Table 13. Alternative Medicines and Therapies: by Distribution Channel(USD Million)
  • Table 14. Alternative Medicines and Therapies Direct Sales , by Region USD Million (2018-2023)
  • Table 15. Alternative Medicines and Therapies E-Sales , by Region USD Million (2018-2023)
  • Table 16. Alternative Medicines and Therapies Distance Correspondence , by Region USD Million (2018-2023)
  • Table 17. South America Alternative Medicines and Therapies, by Country USD Million (2018-2023)
  • Table 18. South America Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 19. South America Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 20. South America Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 21. Brazil Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 22. Brazil Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 23. Brazil Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 24. Argentina Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 25. Argentina Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 26. Argentina Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 27. Rest of South America Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 28. Rest of South America Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 29. Rest of South America Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 30. Asia Pacific Alternative Medicines and Therapies, by Country USD Million (2018-2023)
  • Table 31. Asia Pacific Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 32. Asia Pacific Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 33. Asia Pacific Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 34. China Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 35. China Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 36. China Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 37. Japan Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 38. Japan Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 39. Japan Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 40. India Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 41. India Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 42. India Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 43. South Korea Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 44. South Korea Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 45. South Korea Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 46. Taiwan Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 47. Taiwan Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 48. Taiwan Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 49. Australia Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 50. Australia Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 51. Australia Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 55. Europe Alternative Medicines and Therapies, by Country USD Million (2018-2023)
  • Table 56. Europe Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 57. Europe Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 58. Europe Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 59. Germany Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 60. Germany Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 61. Germany Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 62. France Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 63. France Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 64. France Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 65. Italy Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 66. Italy Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 67. Italy Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 68. United Kingdom Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 69. United Kingdom Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 70. United Kingdom Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 71. Netherlands Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 72. Netherlands Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 73. Netherlands Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 74. Rest of Europe Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 75. Rest of Europe Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 76. Rest of Europe Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 77. MEA Alternative Medicines and Therapies, by Country USD Million (2018-2023)
  • Table 78. MEA Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 79. MEA Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 80. MEA Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 81. Middle East Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 82. Middle East Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 83. Middle East Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 84. Africa Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 85. Africa Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 86. Africa Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 87. North America Alternative Medicines and Therapies, by Country USD Million (2018-2023)
  • Table 88. North America Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 89. North America Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 90. North America Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 91. United States Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 92. United States Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 93. United States Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 94. Canada Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 95. Canada Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 96. Canada Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 97. Mexico Alternative Medicines and Therapies, by Type USD Million (2018-2023)
  • Table 98. Mexico Alternative Medicines and Therapies, by Application USD Million (2018-2023)
  • Table 99. Mexico Alternative Medicines and Therapies, by Distribution Channel USD Million (2018-2023)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Alternative Medicines and Therapies: by Type(USD Million)
  • Table 110. Alternative Medicines and Therapies Mud Therapy , by Region USD Million (2025-2030)
  • Table 111. Alternative Medicines and Therapies Reiki , by Region USD Million (2025-2030)
  • Table 112. Alternative Medicines and Therapies Oil Massage Therapy , by Region USD Million (2025-2030)
  • Table 113. Alternative Medicines and Therapies Magnetic Therapy , by Region USD Million (2025-2030)
  • Table 114. Alternative Medicines and Therapies Some Breathing Exercises , by Region USD Million (2025-2030)
  • Table 115. Alternative Medicines and Therapies Meditation , by Region USD Million (2025-2030)
  • Table 116. Alternative Medicines and Therapies Yoga , by Region USD Million (2025-2030)
  • Table 117. Alternative Medicines and Therapies Osteopathic Manipulation , by Region USD Million (2025-2030)
  • Table 118. Alternative Medicines and Therapies: by Application(USD Million)
  • Table 119. Alternative Medicines and Therapies Hospital  , by Region USD Million (2025-2030)
  • Table 120. Alternative Medicines and Therapies Clinic , by Region USD Million (2025-2030)
  • Table 121. Alternative Medicines and Therapies: by Distribution Channel(USD Million)
  • Table 122. Alternative Medicines and Therapies Direct Sales , by Region USD Million (2025-2030)
  • Table 123. Alternative Medicines and Therapies E-Sales , by Region USD Million (2025-2030)
  • Table 124. Alternative Medicines and Therapies Distance Correspondence , by Region USD Million (2025-2030)
  • Table 125. South America Alternative Medicines and Therapies, by Country USD Million (2025-2030)
  • Table 126. South America Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 127. South America Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 128. South America Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 129. Brazil Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 130. Brazil Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 131. Brazil Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 132. Argentina Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 133. Argentina Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 134. Argentina Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 135. Rest of South America Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 136. Rest of South America Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 137. Rest of South America Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 138. Asia Pacific Alternative Medicines and Therapies, by Country USD Million (2025-2030)
  • Table 139. Asia Pacific Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 140. Asia Pacific Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 141. Asia Pacific Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 142. China Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 143. China Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 144. China Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 145. Japan Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 146. Japan Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 147. Japan Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 148. India Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 149. India Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 150. India Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 151. South Korea Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 152. South Korea Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 153. South Korea Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 154. Taiwan Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 155. Taiwan Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 156. Taiwan Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 157. Australia Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 158. Australia Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 159. Australia Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 160. Rest of Asia-Pacific Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 161. Rest of Asia-Pacific Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 162. Rest of Asia-Pacific Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 163. Europe Alternative Medicines and Therapies, by Country USD Million (2025-2030)
  • Table 164. Europe Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 165. Europe Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 166. Europe Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 167. Germany Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 168. Germany Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 169. Germany Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 170. France Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 171. France Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 172. France Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 173. Italy Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 174. Italy Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 175. Italy Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 176. United Kingdom Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 177. United Kingdom Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 178. United Kingdom Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 179. Netherlands Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 180. Netherlands Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 181. Netherlands Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 182. Rest of Europe Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 183. Rest of Europe Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 184. Rest of Europe Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 185. MEA Alternative Medicines and Therapies, by Country USD Million (2025-2030)
  • Table 186. MEA Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 187. MEA Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 188. MEA Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 189. Middle East Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 190. Middle East Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 191. Middle East Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 192. Africa Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 193. Africa Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 194. Africa Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 195. North America Alternative Medicines and Therapies, by Country USD Million (2025-2030)
  • Table 196. North America Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 197. North America Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 198. North America Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 199. United States Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 200. United States Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 201. United States Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 202. Canada Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 203. Canada Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 204. Canada Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 205. Mexico Alternative Medicines and Therapies, by Type USD Million (2025-2030)
  • Table 206. Mexico Alternative Medicines and Therapies, by Application USD Million (2025-2030)
  • Table 207. Mexico Alternative Medicines and Therapies, by Distribution Channel USD Million (2025-2030)
  • Table 208. Research Programs/Design for This Report
  • Table 209. Key Data Information from Secondary Sources
  • Table 210. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Alternative Medicines and Therapies: by Type USD Million (2018-2023)
  • Figure 5. Global Alternative Medicines and Therapies: by Application USD Million (2018-2023)
  • Figure 6. Global Alternative Medicines and Therapies: by Distribution Channel USD Million (2018-2023)
  • Figure 7. South America Alternative Medicines and Therapies Share (%), by Country
  • Figure 8. Asia Pacific Alternative Medicines and Therapies Share (%), by Country
  • Figure 9. Europe Alternative Medicines and Therapies Share (%), by Country
  • Figure 10. MEA Alternative Medicines and Therapies Share (%), by Country
  • Figure 11. North America Alternative Medicines and Therapies Share (%), by Country
  • Figure 12. Global Alternative Medicines and Therapies share by Players 2023 (%)
  • Figure 13. Global Alternative Medicines and Therapies share by Players (Top 3) 2023(%)
  • Figure 14. Global Alternative Medicines and Therapies share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Weleda (Switzerland) Revenue, Net Income and Gross profit
  • Figure 17. Weleda (Switzerland) Revenue: by Geography 2023
  • Figure 18. Cipla (India) Revenue, Net Income and Gross profit
  • Figure 19. Cipla (India) Revenue: by Geography 2023
  • Figure 20. Sante Verte Lab (France) Revenue, Net Income and Gross profit
  • Figure 21. Sante Verte Lab (France) Revenue: by Geography 2023
  • Figure 22. Sandoz International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Sandoz International GmbH (Germany) Revenue: by Geography 2023
  • Figure 24. Biocon Ltd (India) Revenue, Net Income and Gross profit
  • Figure 25. Biocon Ltd (India) Revenue: by Geography 2023
  • Figure 26. Dr. Reddy's Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 27. Dr. Reddy's Laboratories (India) Revenue: by Geography 2023
  • Figure 28. Wright Health Group Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Wright Health Group Ltd. (United Kingdom) Revenue: by Geography 2023
  • Figure 30. Nordic Nutraceuticals (Denmark) Revenue, Net Income and Gross profit
  • Figure 31. Nordic Nutraceuticals (Denmark) Revenue: by Geography 2023
  • Figure 32. Pure encapsulations, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 33. Pure encapsulations, LLC (United States) Revenue: by Geography 2023
  • Figure 34. Global Alternative Medicines and Therapies: by Type USD Million (2025-2030)
  • Figure 35. Global Alternative Medicines and Therapies: by Application USD Million (2025-2030)
  • Figure 36. Global Alternative Medicines and Therapies: by Distribution Channel USD Million (2025-2030)
  • Figure 37. South America Alternative Medicines and Therapies Share (%), by Country
  • Figure 38. Asia Pacific Alternative Medicines and Therapies Share (%), by Country
  • Figure 39. Europe Alternative Medicines and Therapies Share (%), by Country
  • Figure 40. MEA Alternative Medicines and Therapies Share (%), by Country
  • Figure 41. North America Alternative Medicines and Therapies Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Weleda (Switzerland)
  • Cipla (India)
  • Sante Verte Lab (France)
  • Sandoz International GmbH (Germany)
  • Biocon Ltd (India)
  • Dr. Reddy's Laboratories (India)
  • Wright Health Group Ltd. (United Kingdom)
  • Nordic Nutraceuticals (Denmark)
  • Pure encapsulations, LLC (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 249 Pages 64 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Weleda (Switzerland), Cipla (India), Sante Verte Lab (France), Sandoz International GmbH (Germany), Biocon Ltd (India), Dr. Reddy's Laboratories (India), Wright Health Group Ltd. (United Kingdom), Nordic Nutraceuticals (Denmark) and Pure encapsulations, LLC (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Health Care Expenditure" is seen as one of major influencing trends for Alternative Medicines and Therapies Market during projected period 2023-2030.
The Alternative Medicines and Therapies market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Alternative Medicines and Therapies Report?